PEPID Pulse
  • Blog
  • Alerts
  • Press
  • pepid.com
Select Page

First Treatment for Post-partum Depression FDA Approved

by PEPID Newsroom | Mar 19, 2019 | Alerts

Tuesday, March 19, the FDA approved Zulresso (brexanolone) injection for intravenous (IV) use to treat post-partum depression (PPD) in adult women. No other drug before now has been approved to specifically treat PPD. Zulresso will be available through Risk Evaluation...
Annual World Breastfeeding Week and the Benefits of Breastfeeding

Annual World Breastfeeding Week and the Benefits of Breastfeeding

by PEPID Newsroom | Aug 3, 2018 | Emergency Medicine, Nursing, Pharmacy, Primary Care, Uncategorized

August kicks off with World Breastfeeding Week, now on its 27th year since it was first celebrated by the World Alliance for Breastfeeding Action (WABA) in 1992. Every August 1-7, WABA partners with a worldwide network of organizations to encourage breastfeeding,...

Recent Posts

  • The Summer Injury Spike: Common ER Visits and How to Prevent Them
  • Men’s Health Month – Closing Gaps in Prevention and Early Detection
  • Beyond the Beach – Occupational Skin Cancer Risks in Outdoor Workers
  • Tackling Antimicrobial Resistance: How to fight back against the rise in tough cases
  • The ‘Forever Chemicals’ Crisis: What Healthcare Providers Need to Know About PFAS

Categories

  • Alerts
  • Emergency Medicine
  • Featured Posts
  • Nursing
  • Pharmacy
  • Press & Media
  • Primary Care
  • Uncategorized
PEPID, LLC. All rights reserved